Abstract:To investigate the efficacy of adjunctive use of bispectral index (BIS) monitoring to titrate sedation for endoscopic radiofrequency management of gastroesophageal reflux disease (GERD).?Methods?Ninety patients underwent elective endoluminal radiofrequency ablation for GERD under sedation were prospectively randomized divided into two groups with the BIS value either visible (BIS group, n?=?45) or invisible (control group, n?=?45) to the anesthesiologist. Patients in both groups received propofol as the main drug for sedation with adjunctive use of dexmedetomidine and sufentanil. Sedation depth was monitored according to routine practice using the modified Observer’s Assessment of Alertness/Sedation (MOAA/S) Scale (MOAA/S score 0 to 1). In the BIS group, the anesthesiologist also used the BIS value for titration of sedation, and targeted BIS values between 55 and 70. The incidences of sedation-related adverse events (including body movement, abnormal blood pressure, bradycardia, tachycardia, arrhythmia and hypoxemia), hemodynamic stability, the depth of sedation, the doses of propofol administered, and the satisfaction scores (scale of 0?~?10) of patients and endoscopists were compared between groups.?Results?A low incidence of body movement was observed in the BIS group compared with control (P?=?0.030) with no between-group differences in the incidences of cardiopulmonary adverse events, heart rates, blood pressure or oxygen saturation ( all P?>?0.05). MOAA/S (P?=?0.018) and BIS value (P?=?0.000) were higher, propofol consumption was less (P?=?0.034) and endoscopists’ satisfaction score (P?=?0.007) was higher in the BIS group compared with those in control. No difference was found for patients’ satisfaction score (P?=?0.243).?Conclusions?BIS-assisted sedation for endoscopic radiofrequency management of GERD was superior to sedation titrated by routine clinical practice with less body movements, higher endoscopists’ satisfaction score, lower consumption of sedatives and lighter depth of sedation.